Benchmarks › Hydration, Therapeutic, Prophylactic, Diagnostic Injections and Infusions and Chemotherapy and Other Highly Complex Biologic Agent Administration
Hydration, Therapeutic, Prophylactic, Diagnostic Injections and Infusions and Chemotherapy and Other Highly Complex Biologic Agent Administration: Federal IDR benchmarks
In 2025-Q4 the median prevailing offer for Hydration, Therapeutic, Prophylactic, Diagnostic Injections and Infusions and Chemotherapy and Other Highly Complex Biologic Agent Administration (CPT 96360 - 96549) was 424% of the QPA, across 20,079 payment determinations covering 42,499 items or services.
| Quarter | Median prevailing offer, % of QPA | Determinations | Items or services |
|---|---|---|---|
| 2025-Q1 | 368% | 8,035 | 15,917 |
| 2025-Q2 | 400% | 14,101 | 28,729 |
| 2025-Q3 | 428% | 24,313 | 53,843 |
| 2025-Q4 | 424% | 20,079 | 42,499 |
Source: CMS Federal IDR Supplemental Tables, reporting year 2025 (CMS reports page). Quarterly medians cannot be combined into a yearly median, so each quarter is shown separately.
What this does and does not tell you
A median describes the middle of past outcomes for the whole specialty. It is not a prediction for a specific claim: the QPA band, the plan, the state, the evidence you submit and the entity all matter. Lower-QPA items tend to see higher multiples; see QPA bands.
Estimate a claim in this specialty
Get the next quarterly update
We are building a flat-fee tracker for eligibility, deadlines, batches and payment follow-up. Join the list and we will email you when it opens. No patient information needed.